Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Jan A Stratmann & Martin Sebastian. (2019) Polo-like kinase 1 inhibition in NSCLC: mechanism of action and emerging predictive biomarkers. Lung Cancer: Targets and Therapy 10, pages 67-80.
Read now
Read now
Guillermo de Cárcer, Gerard Manning & Marcos Malumbres. (2011) From Plk1 to Plk5. Cell Cycle 10:14, pages 2255-2262.
Read now
Read now
Puneet Chopra, Gautam Sethi, Sunanda G Dastidar & Abhijit Ray. (2010) Polo-like kinase inhibitors: an emerging opportunity for cancer therapeutics. Expert Opinion on Investigational Drugs 19:1, pages 27-43.
Read now
Read now
Articles from other publishers (19)
Yang Gao, Elena B. Kabotyanski, Jonathan H. Shepherd, Elizabeth Villegas, Deanna Acosta, Clark Hamor, Tingting Sun, Celina Montmeyor-Garcia, Xiaping He, Lacey E. Dobrolecki, Thomas F. Westbrook, Michael T. Lewis, Susan G. Hilsenbeck, Xiang H.-F. Zhang, Charles M. Perou & Jeffrey M. Rosen. (2021) Tumor Suppressor PLK2 May Serve as a Biomarker in Triple-Negative Breast Cancer for Improved Response to PLK1 Therapeutics. Cancer Research Communications 1:3, pages 178-193.
Crossref
Crossref
Styliani Iliaki, Rudi Beyaert & Inna S. Afonina. (2021) Polo-like kinase 1 (PLK1) signaling in cancer and beyond. Biochemical Pharmacology 193, pages 114747.
Crossref
Crossref
Sisi Deng, Xiaoli Lu, Zhi Zhang, Rui Meng, Mi Li & Shilin Xia. (2021) Identification and assessment of PLK1/2/3/4 in lung adenocarcinoma and lung squamous cell carcinoma: Evidence from methylation profile. Journal of Cellular and Molecular Medicine 25:14, pages 6652-6663.
Crossref
Crossref
Monika Kressin, Daniela Fietz, Sven Becker & Klaus Strebhardt. (2021) Modelling the Functions of Polo-Like Kinases in Mice and Their Applications as Cancer Targets with a Special Focus on Ovarian Cancer. Cells 10:5, pages 1176.
Crossref
Crossref
Duo Zhao, Edward Shun, Fengjun Ling, Qing Liu, Ayesha Warsi, Bowen Wang, Qinfeng Zhou, Cuilin Zhu, Hao Zheng, Kexiang Liu & Xiufen Zheng. (2020) Plk2 Regulated by miR-128 Induces Ischemia-Reperfusion Injury in Cardiac Cells. Molecular Therapy - Nucleic Acids 19, pages 458-467.
Crossref
Crossref
Elizabeth M. Matthew, Zhaohai Yang, Suraj Peri, Mark Andrake, Roland Dunbrack, Eric Ross & Wafik S. El-Deiry. (2018) Plk2 Loss Commonly Occurs in Colorectal Carcinomas but not Adenomas: Relationship to mTOR Signaling. Neoplasia 20:3, pages 244-255.
Crossref
Crossref
Neil D. Palmisiano & Margaret T. Kasner. (2015) Polo‐like kinase and its inhibitors: Ready for the match to start?. American Journal of Hematology 90:11, pages 1071-1076.
Crossref
Crossref
Juhee Lim, Hueng-Sik Choi & Hyun Jin Choi. (2015) Estrogen-related receptor gamma regulates dopaminergic neuronal phenotype by activating GSK3β/NFAT signaling in SH-SY5Y cells. Journal of Neurochemistry 133:4, pages 544-557.
Crossref
Crossref
Hyungshin Yim & Raymond L. Erikson. (2014) Plk1-targeted therapies in TP53- or RAS-mutated cancer. Mutation Research/Reviews in Mutation Research 761, pages 31-39.
Crossref
Crossref
Elizabeth VillegasElena B. KabotyanskiAmy N. ShoreChad J. CreightonThomas F. WestbrookJeffrey M. Rosen. (2014) Plk2 regulates mitotic spindle orientation and mammary gland development. Development 141:7, pages 1562-1571.
Crossref
Crossref
Ran Li, Dian-Fu Chen, Rong Zhou, Sheng-Nan Jia, Jin-Shu Yang, James S. Clegg & Wei-Jun Yang. (2012) Involvement of Polo-like Kinase 1 (Plk1) in Mitotic Arrest by Inhibition of Mitogen-activated Protein Kinase-Extracellular Signal-regulated Kinase-Ribosomal S6 Kinase 1 (MEK-ERK-RSK1) Cascade. Journal of Biological Chemistry 287:19, pages 15923-15934.
Crossref
Crossref
Klaus Strebhardt. (2010) Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy. Nature Reviews Drug Discovery 9:8, pages 643-660.
Crossref
Crossref
Jung-Eun Park, Nak-Kyun Soung, Yoshikazu Johmura, Young H. Kang, Chenzhong Liao, Kyung H. Lee, Chi Hoon Park, Marc C. Nicklaus & Kyung S. Lee. (2010) Polo-box domain: a versatile mediator of polo-like kinase function. Cellular and Molecular Life Sciences 67:12, pages 1957-1970.
Crossref
Crossref
Zdenek Andrysik, William Z. Bernstein, Li Deng, David L. Myer, Ya-Qin Li, Jay A. Tischfield, Peter J. Stambrook & El Mustapha Bahassi. (2010) The novel mouse Polo-like kinase 5 responds to DNA damage and localizes in the nucleolus. Nucleic Acids Research 38:9, pages 2931-2943.
Crossref
Crossref
Mark S. Fox & Renee A. Reijo Pera. 2007. The Genetics of Male Infertility. The Genetics of Male Infertility
167
184
.
Drew M Lowery, Daniel Lim & Michael B Yaffe. (2005) Structure and function of Polo-like kinases. Oncogene 24:2, pages 248-259.
Crossref
Crossref
Jeffrey A Winkles & Gregory F Alberts. (2005) Differential regulation of polo-like kinase 1, 2, 3, and 4 gene expression in mammalian cells and tissues. Oncogene 24:2, pages 260-266.
Crossref
Crossref
Wilma L. Lingle, Kara Lukasiewicz & Jeffrey L. Salisbury. 2005. Genome Instability in Cancer Development. Genome Instability in Cancer Development
393
421
.
Dawn C.-I. KOH, A. ARMUGAM & K. JEYASEELAN. (2004) Sputa nerve growth factor forms a preferable substitute to mouse 7S-β nerve growth factor. Biochemical Journal 383:1, pages 149-158.
Crossref
Crossref